Roches Acquisition of Genentech Harvard Case Solution & Analysis

Franz Humer, CEO of Roche, has to decide whether to mount a hostile tender offer of shares owned biotechnology subsidiary Roche, Genentech. The case provides an opportunity to analyze the company's strategy in relation to Roche Genentech, the pros and cons of combining two companies with different cultures, the cost of Genentech, and tactics of hostile tender offer. "Hide
by Carliss Y. Baldwin, Bo Becker, Vincent Dessain Source: Harvard Business School 32 pages. Publication Date: February 26, 2010. Prod. #: 210040-PDF-ENG

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.